In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Juno Therapeutics, Inc. (NASDAQ:JUNO), Abbott Laboratories (NYSE:ABT), Freeport-McMoran, Inc. (NYSE:FCX), HP Inc. (NYSE:HPQ), The Trade Desk Inc. (NASDAQ:TTD), and Platform Specialty Products Corporation (NYSE:PAH), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

JUNO DOWNLOAD: http://Fundamental-Markets.com/register/?so=JUNO ABT DOWNLOAD: http://Fundamental-Markets.com/register/?so=ABT FCX DOWNLOAD: http://Fundamental-Markets.com/register/?so=FCX HPQ DOWNLOAD: http://Fundamental-Markets.com/register/?so=HPQ TTD DOWNLOAD: http://Fundamental-Markets.com/register/?so=TTD PAH DOWNLOAD: http://Fundamental-Markets.com/register/?so=PAH

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Juno Therapeutics, Inc. (NASDAQ:JUNO), Abbott Laboratories (NYSE:ABT), Freeport-McMoran, Inc. (NYSE:FCX), HP Inc. (NYSE:HPQ), The Trade Desk Inc. (NASDAQ:TTD), and Platform Specialty Products Corporation (NYSE:PAH) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. All information in this release was accessed November 24th, 2017. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All amounts in millions (MM), except per share amounts. Percentage calculations are performed after rounding.

-----------------------------------------

JUNO THERAPEUTICS, INC. (JUNO) REPORT OVERVIEW

Juno Therapeutics' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Juno Therapeutics reported revenue of $44.82MM vs $20.83MM (up 115.19%) and diluted earnings per share -$1.12 vs -$0.56. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Juno Therapeutics reported revenue of $79.36MM vs $18.22MM (up 335.66%) and diluted earnings per share -$2.42 vs -$2.72. Juno Therapeutics is expected to report earnings on March 7th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.66. The estimated EPS forecast for the next fiscal year is -$4.40 and is expected to report on March 7th, 2018.

To read the full Juno Therapeutics, Inc. (JUNO) report, download it here: http://Fundamental-Markets.com/register/?so=JUNO

-----------------------------------------

ABBOTT LABORATORIES (ABT) REPORT OVERVIEW

Abbott Laboratories' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Abbott Laboratories reported revenue of $6,829.00MM vs $5,302.00MM (up 28.80%) and diluted earnings per share $0.34 vs -$0.22. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Abbott Laboratories reported revenue of $20,853.00MM vs $20,405.00MM (up 2.20%) and diluted earnings per share $0.94 vs $2.92 (down 67.81%). Abbott Laboratories is expected to report earnings on January 24th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.65. The estimated EPS forecast for the next fiscal year is $2.83 and is expected to report on January 24th, 2018.

To read the full Abbott Laboratories (ABT) report, download it here: http://Fundamental-Markets.com/register/?so=ABT

-----------------------------------------

FREEPORT-MCMORAN, INC. (FCX) REPORT OVERVIEW

Freeport-McMoran's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Freeport-McMoran reported revenue of $4,310.00MM vs $3,877.00MM (up 11.17%) and diluted earnings per share $0.19 vs $0.16 (up 18.75%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, Freeport-McMoran reported revenue of $14,830.00MM vs $14,607.00MM (up 1.53%) and diluted earnings per share -$3.16 vs -$11.31. Freeport-McMoran is expected to report earnings on January 24th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.25. The estimated EPS forecast for the next fiscal year is $1.63 and is expected to report on January 24th, 2018.

To read the full Freeport-McMoran, Inc. (FCX) report, download it here: http://Fundamental-Markets.com/register/?so=FCX

-----------------------------------------

HP INC. (HPQ) REPORT OVERVIEW

HP's Recent Financial Performance

For the three months ended July 31st, 2017 vs July 31st, 2016, HP reported revenue of $13,060.00MM vs $11,892.00MM (up 9.82%) and diluted earnings per share $0.41 vs $0.45 (down 8.89%). For the twelve months ended October 31st, 2016 vs October 31st, 2015, HP reported revenue of $48,238.00MM vs $51,463.00MM (down 6.27%) and diluted earnings per share $1.43 vs $2.48 (down 42.34%). HP is expected to report earnings on February 28th, 2018. The report will be for the fiscal period ending January 31st, 2018. The reported EPS for the same quarter last year was $0.38. The estimated EPS forecast for the next fiscal year is $1.90 and is expected to report on November 20th, 2018.

To read the full HP Inc. (HPQ) report, download it here: http://Fundamental-Markets.com/register/?so=HPQ

-----------------------------------------

THE TRADE DESK INC. (TTD) REPORT OVERVIEW

The Trade Desk's Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, The Trade Desk reported revenue of $79.41MM vs $52.96MM (up 49.96%) and diluted earnings per share $0.23 vs $0.06 (up 283.33%). For the twelve months ended December 31st, 2016 vs December 31st, 2015, The Trade Desk reported revenue of $202.93MM vs $113.84MM (up 78.26%) and diluted earnings per share -$1.46 vs $0.39. The Trade Desk is expected to report earnings on February 15th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.24. The estimated EPS forecast for the next fiscal year is $1.24 and is expected to report on February 15th, 2018.

To read the full The Trade Desk Inc. (TTD) report, download it here: http://Fundamental-Markets.com/register/?so=TTD

-----------------------------------------

PLATFORM SPECIALTY PRODUCTS CORPORATION (PAH) REPORT OVERVIEW

Platform Specialty Products' Recent Financial Performance

For the three months ended September 30th, 2017 vs September 30th, 2016, Platform Specialty Products reported revenue of $904.30MM vs $890.50MM (up 1.55%) and diluted earnings per share -$0.24 vs -$0.15. For the twelve months ended December 31st, 2016 vs December 31st, 2015, Platform Specialty Products reported revenue of $3,585.90MM vs $2,542.30MM (up 41.05%) and diluted earnings per share -$0.65 vs -$1.52. Platform Specialty Products is expected to report earnings on February 27th, 2018. The report will be for the fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.20. The estimated EPS forecast for the next fiscal year is $0.94 and is expected to report on February 27th, 2018.

To read the full Platform Specialty Products Corporation (PAH) report, download it here: http://Fundamental-Markets.com/register/?so=PAH

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact: Andrew Duffie, Media Department Office: +1 667-401-0010 E-mail: media@Fundamental-Markets.com

© 2017 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

JUNO THERAPEUTICS, INC. (NASDAQ:JUNO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more JUNO THERAPEUTICS, INC. Charts.
JUNO THERAPEUTICS, INC. (NASDAQ:JUNO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more JUNO THERAPEUTICS, INC. Charts.